Congenital Urine Flow Impairments of the Upper Urinary Tract: Pathophysiology and Experimental Studies

Pediatric Urology

Volumn , Issue , 2010, Pages 237-247

  Peters, Craig A ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952267304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3204-5.00019-0     Document Type: Chapter

References (226)

1. Lebowitz R.L., Griscom N.T. Neonatal hydronephrosis: 146 cases. Radiol Clin North Am 1977, 15:49-59.
2. Flashner S.C., King L.R. Ureteropelvic junction. Clinical Pediatric Urology 1992, 693-725. W.B. Saunders, Philadelphia, vol. 2. P.P. Kelalis, L.R. King, A.B. Belman (Eds.).
3. Johnston J.H., Evans J.P., Glassberg K.I., Shapiro S.R. Pelvic hydronephrosis in children: a review of 219 personal cases. J Urol 1977, 117:97-101.
4. Kelalis P.P., Culp O.S., Stickler G.B., Burke E.C. Ureteropelvic obstruction in children: experiences with 109 cases. J Urol 1971, 106:418-422.
5. Robson W.J., Rudy S.M., Johnston J.H. Pelviureteric obstruction in infancy. J Pediatr Surg 1976, 11:57-61.
6. Perlmutter A.D., Kroovand R.L., Lai Y.W. Management of ureteropelvic obstruction in the first year of life. J Urol 1980, 123:535-537.
7. Snyder H.M.D., Lebowitz R.L., Colodny A.H., et al. Ureteropelvic junction obstruction in children. Urol Clin North Am 1980, 7:273-290.
8. Koff S.A. Problematic ureteropelvic junction obstruction. J Urol. 1987, 138:390.
9. Peters C.A. Urinary obstruction in children. J Urol. 1995, 154:1874-1884.
10. Hanna M.K., Jeffs R.D., Sturgess J.M., Baskin M. Ureteral structure and ultrastructure, part II: congenital ureteropelvic junction obstruction and primary obstructive megaureter. J Urol 1976, 116:725-730.
11. Koff S.A., Thrall J.H. Diagnosis of obstruction in experimental hydroureteronephrosis. Urology 1981, 17:570-577.
12. Dietl: Nerki wedrujace i ich uwiezgnienie. Przegl. Lek., Krakow, 3: 225, 1864.
13. Johnston J.H. The pathogenesis of hydronephrosis in children. Br J Urol 1969, 41:724-734.
14. Stephens F.D. Ureterovascular hydronephrosis and the "aberrant" renal vessels. J Urol 1982, 128:984-987.
15. Lebowitz R.L., Johan B.G. The coexistence of ureteropelvic junction obstruction and reflux. Am J Radiol. 1982, 140:231-238.
16. Bernstein G.T., Mandell J., Lebowitz R.L., et al. Ureteropelvic junction obstruction in the neonate. J Urol 1988, 140:1216-1221.
17. Hollowell J.G., Altman H.G., Snyder H.M.D., Duckett J.W. Coexisting ureteropelvic junction obstruction and vesicoureteral reflux: diagnostic and therapeutic implications. J Urol 1989, 142:490-493.
18. Stauss J., Connolly L.P., Connolly S.A., et al. Dynamic renal scintigraphy in children with vesicoureteral reflux and suspected coexisting ureteropelvic junction obstruction. J Urol 2003, 170:1966-1970.
19. Brown T., Mandell J., Lebowitz R.L. Neonatal hydronephrosis in the era of sonography. AJR Am J Roentgenol 1987, 148:959-963.
20. Cain M.P., Rink R.C., Thomas A.C., et al. Symptomatic ureteropelvic junction obstruction in children in the era of prenatal sonography-is there a higher incidence of crossing vessels?. Urology 2001, 57:338-341.
21. Rooks V.J., Lebowitz R.L. Extrinsic ureteropelvic junction obstruction from a crossing renal vessel: demography and imaging. Pediatr Radiol 2001, 31:120-124.
22. Williams D.I., Kenawi M.M. The prognosis of pelviureteric obstruction in childhood: a review of 190 cases. Eur Urol 1976, 2:57-63.
23. McCrory W.W. Regulation of renal functional development. Urol Clin North Am 1980, 7:243-264.
24. Blyth B., Snyder H.M., Duckett J.W. Antenatal diagnosis and subsequent management of hydronephrosis. J Urol 1993, 149:693-698.
25. Alcaraz A., Vinaixa F., Tejedo-Mateu A., et al. Obstruction and recanalization of the ureter during embryonic development. J Urol 1991, 145:410-416.
26. Ostling K. The genesis of hydronephrosis: particularly with regard to the changes at the ureteropelvic junction. Acta Scand 1942, 86:1-118.
27. Bush K.T., Vaughn D.A., Li X., et al. Development and differentiation of the ureteric bud into the ureter in the absence of a kidney collecting system. Dev Biol 2006, 298:571-584.
28. Antonakopoulos G.N., Fuggle W.J., Newman J., et al. Idiopathic hydronephrosis. Arch Pathol Lab Med 1985, 109:1097-1101.
29. Maizels M., Stephens F.D. Valves of the ureter as a cause of primary obstruction of the ureter: anatomic, embryologic and clinical aspects. J Urol 1980, 123:742-747.
30. Ruano-Gil D., Coca-Payeras A., Tejedo-Mateu A. Obstruction and normal recanalization of the ureter in the human embryo: its relation to congenital ureteric obstruction. Eur Urol 1975, 1:287-293.
31. Starr N.T., Maizels M., Chou P., et al. Microanatomy and morphometry of the hydronephrotic "obstructed" renal pelvis in asymptomatic infants. J Urol. 1992, 148:519-524.
32. Whitaker R.H. Urodynamic assessment of ureteral obstruction in retroperitoneal fibrosis. J Urol. 1975, 113:26-29.
33. Notley R.G. Electron microscopy of the upper ureter and the pelvi-ureteric junction. Br J Urol 1968, 40:37-52.
34. Notley R.G. Electron microscopy of the primary obstructive megaureter. Br J Urol 1972, 44:229-234.
35. Murakumo M., Nonomura K., Yamashita T., et al. Structural changes of collagen components and diminution of nerves in congenital ureteropelvic junction obstruction. J Urol 1997, 157:1963-1968.
36. Wang Y., Puri P., Hassan J., et al. Abnormal innervation and altered nerve growth factor messenger ribonucleic acid expression in ureteropelvic junction obstruction. J Urol 1995, 154:679-683.
37. Demirbilek S., Edali M.N., Gurunluoglu K., et al. Glial cell line-derived neurotrophic factor and synaptophysin expression in pelviureteral junction obstruction. Urology 2006, 67:400-405.
38. Harish J., Joshi K., Rao K.L., et al. Pelviureteric junction obstruction: how much is the extent of the upper ureter with defective innervation needing resection?. J Pediatr Surg 2003, 38:1194-1198.
39. Kajbafzadeh A.M., Payabvash S., Salmasi A.H., et al. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction. J Urol 2006, 176:718-723.
40. Chiou Y.Y., Shieh C.C., Cheng H.L., Tang M.J. Intrinsic expression of Th2 cytokines in urothelium of congenital ureteropelvic junction obstruction. Kidney Int 2005, 67:638-646.
41. McLellan D.L., Retik A.B., Bauer S.B., et al. Rate and predictors of spontaneous resolution of prenatally diagnosed primary nonrefluxing megaureter. J Urol 2002, 168:2177-2180.
42. Cartwright P.C., Duckett J.W., Keating M.A., et al. Managing apparent ureteropelvic junction obstruction in the newborn. J Urol 1992, 148:1224-1228.
43. Koff S.A., Campbell K.D. The nonoperative management of unilateral neonatal hydronephrosis: natural history of poorly functioning kidneys. J Urol 1994, 152:593-595.
44. Yeung C.K., Godley M.L., Dhillon H.K., et al. Urodynamic patterns in infants with normal lower urinary tracts or primary vesico-ureteric reflux. Br J Urol 1998, 81:461-467.
45. Gobet R., Bleakley J., Peters C.A. Premature urachal closure induces hydroureteronephrosis in male fetuses. J Urol 1998, 160:1463-1467.
46. Nishimura H., Yerkes E., Hohenfellner K., et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999, 3:1-10.
47. Ichikawa I., Kuwayama F., Pope J.C.T., et al. Paradigm shift from classic anatomic theories to contemporary cell biological views of CAKUT. Kidney Int 2002, 61:889-898.
48. Miyazaki Y., Tsuchida S., Nishimura H., et al. Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest 1998, 102:1489-1497.
49. Yerkes E., Nishimura H., Miyazaki Y., et al. Role of angiotensin in the congenital anomalies of the kidney and urinary tract in the mouse and the human. Kidney Int Suppl 1998, 67:S75-77.
50. Niimura F., Kon V., Ichikawa I. The renin-angiotensin system in the development of the congenital anomalies of the kidney and urinary tract. Curr Opin Pediatr 2006, 18:161-166.
51. Santis W.F., Peters C.A., Yalla S.V., Sullivan M.P. Ureteral function is modulated by a local renin-angiotensin system. J Urol 2003, 170:259-263.
52. Oshima K., Miyazaki Y., Brock J.W., et al. Angiotensin type II receptor expression and ureteral budding. J Urol 2001, 166:1848-1852.
53. Gomez R.A., Norwood V.F. Developmental consequences of the renin-angiotensin system. Am J Kidney Dis 1995, 26:409-431.
54. Tufro-McReddie A., Romano L.M., Harris J.M., et al. Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 1995, 269:F110-F115.
55. Peters C.A. Obstruction of the fetal urinary tract. J Am Soc Nephrol 1997, 8:653-663.
56. Bernstein J. Developmental abnormalities of the renal parenchyma-renal hypoplasia and dysplasia. Pathol Annu 1968, 3:213.
57. Matsell D.G. Renal dysplasia: new approaches to an old problem. Am J Kidney Dis 1998, 32:535-543.
58. Beck A.D. The effect of intra-uterine urinary obstruction upon the development of the fetal kidney. J Urol 1971, 105:784-789.
59. Gonzalez R., Reinberg Y., Burke B., et al. Early bladder outlet obstruction in fetal lambs induces renal dysplasia and the prune-belly syndrome. J Pediatr Surg 1990, 25:342-345.
60. Peters C.A., Carr M.C., Lais A., et al. The response of the fetal kidney to obstruction. J Urol. 1992, 148:503-509.
61. Matsell D.G., Bennett T., Bocking A.D. Characterization of fetal ovine renal dysplasia after mid-gestation ureteral obstruction. Clin Invest Med 1996, 19:444-452.
62. Tarantal A.F., Han V.K., Cochrum K.C., et al. Fetal rhesus monkey model of obstructive renal dysplasia. Kidney Int 2001, 59:446-456.
63. Elder J.S., Stansbrey R., Dahms B.B., Selzman A.A. Renal histological changes secondary to ureteropelvic junction obstruction. J Urol 1995, 154:719-722.
64. Stock J.A., Krous H.F., Heffernan J., et al. Correlation of renal biopsy and radionuclide renal scan differential function in patients with unilateral ureteropelvic junction obstruction. J Urol 1995, 154:716-718.
65. Huang W.Y., Peters C.A., Zurakowski D., et al. Renal biopsy in congenital ureteropelvic junction obstruction: evidence for parenchymal maldevelopment. Kidney Int 2006, 69:137-143.
66. Zhang P.L., Peters C.A., Rosen S. Ureteropelvic junction obstruction: morphological and clinical studies. Pediatr Nephrol 2000, 14:820-826.
67. Morita T., Wada I., Saeki H., et al. Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs. J Urol 1987, 137:132-135.
68. Weiss R.M., Biancani P. Rationale for ureteral tapering. Urology 1982, 20:482-487.
69. Shapiro S.R., Woerner S., Adelman R.D., Palmer J.M. Diabetes insipidus and hydronephrosis. J Urol 1978, 119:715-719.
70. Santis W.F., Sullivan M.P., Gobet R., et al. Characterization of ureteral dysfunction in an experimental model of congenital bladder outlet obstruction. J Urol 2000, 163:980-984.
71. Tanagho E.A. Surgically induced partial urinary obstruction in the fetal lamb, 3: ureteral obstruction. Invest Urol 1972, 10:35-52.
72. Mortensen J., Christiansen P., Harving N., et al. Pyeloureteral dynamics: pelvic pressure and kidney function in partial long-term ureteric obstruction. Scand J Urol Nephrol 1989, 23:25-29.
73. Mortensen J., Frokiaer J., Tofft H.P., Djurhuus J.C. The influence of pyeloureteral peristalsis on pelvic pressure during increase in flow rate. Urol Res 1988, 16:295-297.
74. Wen J.G., Chen Y., Froklaer J., et al. Experimental partial unilateral ureter obstruction, I: pressure flow relationship in a rat model with mild and severe acute ureter obstruction. J Urol 1998, 160:1567-1571.
75. Djurhuus J.C., Constantinou C.E. Chronic ureteric obstruction and its impact on the coordinating mechanisms of peristalsis (pyeloureteric pacemaker system). Urol Res 1982, 10:267-270.
76. Gearhart J.P., Lee B.R., Partin A.W., et al. A quantitative histological evaluation of the dilated ureter of childhood, II: ectopia, posterior urethral valves and the prune belly syndrome. J Urol 1995, 153:172-176.
77. Lee B.R., Partin A.W., Epstein J.I., et al. A quantitative histological analysis of the dilated ureter of childhood. J Urol 1992, 148:1482-1486.
78. Lee B.R., Silver R.I., Partin A.W., et al. A quantitative histologic analysis of collagen subtypes: the primary obstructed and refluxing megaureter of childhood. Urology 1998, 51:820-823.
79. Borer J.G., Park J.M., Atala A., et al. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction. Lab Invest 1999, 79:1335-1345.
80. Nguyen H.T., Park J.M., Peters C.A., et al. Cell-specific activation of the HB-EGF and ErbB1 genes by stretch in primary human bladder cells [letter]. In Vitro Cell Dev Biol Anim 1999, 35:371-375.
81. Park J.M., Borer J.G., Freeman M.R., Peters C.A. Stretch activates heparin-binding EGF-like growth factor expression in bladder smooth muscle cells. Am J Physiol 1998, 275:C1247-C1254.
82. Nguyen H.T., Adam R.M., Bride S.H., et al. Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells. Am J Physiol Cell Physiol 2000, 279:C1155-C1167.
83. Bloom D.A., Lebowitz R.L., Bauer S.B. Correlation of cystographic bladder morphology and neuroanatomy in boys with posterior urethral valves. Pediatr Radiol 1997, 27:553-556.
84. Stehr M., Adam R.M., Khoury J., et al. Platelet derived growth factor-BB is a potent mitogen for rat ureteral and human bladder smooth muscle cells: dependence on lipid rafts for cell signaling. J Urol 2003, 169:1165-1170.
85. Chevalier R.L. Perinatal obstructive nephropathy. Semin Perinatol 2004, 28:124-131.
86. Chevalier R.L. Pathogenesis of renal injury in obstructive uropathy. Curr Opin Pediatr 2006, 18:153-160.
87. Smith F.G., Robillard J.E. Pathophysiology of fetal renal disease. Semin Perinatol 1989, 13:305-319.
88. Carr M.C., Schlussel R.N., Peters C.A., et al. Expression of cell growth regulated genes in the fetal kidney: relevance to in utero obstruction. J Urol 1995, 154:242-246.
89. Sumpio B.E., Banes A.J., Levin L.G., Johnson G.J. Mechanical stress stimulates aortic endothelial cells to proliferate. J Vasc Surg 1987, 6:252-256.
90. Vandenburgh H.H., Hatfaludy S., Karlisch P., Shansky J. Mechanically induced alterations in cultured skeletal muscle growth. J Biomech 1991, 1:91-99.
91. Chevalier R.L. Obstructive nephropathy: lessons from cystic kidney disease. Nephron 2000, 84:6-12.
92. Tanner G.A., McQuillan P.F., Maxwell M.R., et al. An in vitro test of the cell stretch-proliferation hypothesis of renal cyst enlargement. J Am Soc Nephrol 1995, 6:1230-1241.
93. Hsieh M.H., Nguyen H.T. Molecular mechanism of apoptosis induced by mechanical forces. Int Rev Cytol 2005, 245:45-90.
94. Nguyen H.T., Bride S.H., Badawy A.B., et al. Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis. Am J Pathol 2000, 156:889-898.
95. Nguyen H.T., Hsieh M.H., Gaborro A., et al. JNK/SAPK and p38 SAPK-2 mediate mechanical stretch-induced apoptosis via caspase-3 and -9 in NRK-52E renal epithelial cells. Nephron Exp Nephrol 2006, 102:e49-e61.
96. Kiley S.C., Thornhill B.A., Belyea B.C., et al. Epidermal growth factor potentiates renal cell death in hydronephrotic neonatal mice, but cell survival in rats. Kidney Int 2005, 68:504-514.
97. Kennedy W.A., Stenberg A., Lackgren G., et al. Renal tubular apoptosis after partial ureteral obstruction. J Urol 1994, 152:658-664.
98. Kennedy W.A., Buttyan R., Garcia-Montes E., et al. Epidermal growth factor suppresses renal tubular apoptosis following ureteral obstruction. Urology 1997, 49:973-980.
99. Samnakay N., Orford J., Barker A., et al. Timing of morphologic and apoptotic changes in the sheep fetal kidney in response to bladder outflow obstruction. J Pediatr Urol 2006, 2:216-224.
100. Seseke F., Thelen P., Ringert R.H. Characterization of an animal model of spontaneous congenital unilateral obstructive uropathy by cDNA microarray analysis. Eur Urol 2004, 45:374-381.
101. Winyard P.J., Nauta J., Lirenman D.S., et al. Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 1996, 49:135-146.
102. Winyard P.J., Risdon R.A., Sams V.R., et al. The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J Clin Invest 1996, 98:451-459.
103. Woolf A.S., Winyard P.J. Gene expression and cell turnover in human renal dysplasia. Histol Histopathol 2000, 15:159-166.
104. Cachat F., Lange-Sperandio B., Chang A.Y., et al. Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 2003, 63:564-575.
105. Chung K.H., Gomez R.A., Chevalier R.L. Regulation of renal growth factors and clusterin by AT1 receptors during neonatal ureteral obstruction. Am J Physiol 1995, 268:F1117-F1123.
106. Kiley S.C., Thornhill B.A., Tang S.S., et al. Growth factor-mediated phosphorylation of proapoptotic BAD reduces tubule cell death in vitro and in vivo. Kidney Int 2003, 63:33-42.
107. Yoo K.H., Thornhill B.A., Forbes M.S., et al. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int 2006, 70:1735-1741.
108. Chevalier R.L., Goyal S., Thornhill B.A. EGF improves recovery following relief of unilateral ureteral obstruction in the neonatal rat. J Urol 1999, 162:1532-1536.
109. Meldrum K.K., Metcalfe P., Leslie J.A., et al. TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res 2006, 131:182-188.
110. Misseri R., Meldrum D.R., Dinarello C.A., et al. TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol 2005, 288:F406-F411.
111. Ayan S., Roth J.A., Freeman M.R., et al. Partial ureteral obstruction dysregulates the renal renin-angiotensin system in the fetal sheep kidney. Urology 2001, 58:301-306.
112. Docherty N.G., O'sullivan O.E., Healy D.A., et al. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol 2006, 290:F4-F13.
113. Power R.E., Doyle B.T., Higgins D., et al. Mechanical deformation induced apoptosis in human proximal renal tubular epithelial cells is caspase dependent. J Urol 2004, 171:457-461.
114. Riser B.L., Cortes P., Zhao X., et al. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992, 90:1932-1943.
115. Ziyadeh F.N., Sharma K., Ericksen M., Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 1994, 93:536-542.
116. Hay E.D., Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995, 26:678-690.
117. Bascands J.L., Schanstra J.P. Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 2005, 68:925-937.
118. Docherty N.G., O'sullivan O.E., Healy D.A., et al. TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 2006, 290:F1202-F1212.
119. Monte J.C., Sakurai H., Bush K.T., Nigam S.K. The developmental nephrome: systems biology in the developing kidney. Curr Opin Nephrol Hypertens 2007, 16:3-9.
120. Berman D.J., Maizels M. The role of urinary obstruction in the genesis of renal dysplasia: a model in the chick embryo. J Urol. 1982, 128:1091-1096.
121. Maizels M., Simpson S.B. Primitive ducts of renal dysplasia induced by culturing ureteral buds denuded of condensed renal mesenchyme. Science 1983, 219:509-510.
122. Woolf A.S. Molecular control of nephrogenesis and the pathogenesis of kidney malformations. Br J Urol 1998, (81 (Suppl 2):1-7.
123. Woolf A.S. Congential obstructive nephropathy gets complicated. Kidney Int 2003, 63:761-763.
124. Woolf A.S., Cale C.M. Roles of growth factors in renal development. Curr Opin Nephrol Hypertens 1997, 6:10-14.
125. Attar R., Quinn F., Winyard P.J., et al. Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys. Am J Pathol 1998, 152:1225-1235.
126. Nguyen H.T., Thomson A.A., Kogan B.A., et al. Expression of the. Wnt gene family during late nephrogenesis and complete ureteral obstruction. Lab Invest 1999, 79:647-658.
127. Eskild-Jensen A., Frokiaer J., Djurhuus J.C., et al. Reduced number of glomeruli in kidneys with neonatally induced partial ureteropelvic obstruction in pigs. J Urol 2002, 167:1435-1439.
128. Chevalier R.L., Thornhill B.A., Wolstenholme J.T., Kim A. Unilateral ureteral obstruction in early development alters renal growth: dependence on the duration of obstruction. J Urol 1999, 161:309-313.
129. Frokiaer J., Christensen B.M., Marples D., et al. Downregulation of aquaporin-2 parallels changes in renal water excretion in unilateral ureteral obstruction. Am J Physiol 1997, 273:F213-F223.
130. Frokiaer J., Marples D., Knepper M.A., Nielsen S. Bilateral ureteral obstruction downregulates expression of vasopressin-sensitive AQP-2 water channel in rat kidney. Am J Physiol 1996, 270:F657-668.
131. Shi Y., Li C., Thomsen K., et al. Neonatal ureteral obstruction alters expression of renal sodium transporters and aquaporin water channels. Kidney Int 2004, 66:203-215.
132. Li C., Wang W., Knepper M.A., et al. Downregulation of renal aquaporins in response to unilateral ureteral obstruction. Am J Physiol Renal Physiol 2003, 284:F1066-F1079.
133. Li C., Wang W., Kwon T.H., et al. Downregulation of AQP1, -2, and -3 after ureteral obstruction is associated with a long-term urine-concentrating defect. Am J Physiol Renal Physiol 2001, 281:F163-F171.
134. Gobet R., Norregaard R., Cisek L., et al. Experimental congenital vesicoureterol reflux in sheep is associated with reduced renal expression levels of aquaporin 1 and 2. J Urol 2008, 179:2396-2401.
135. Herzlinger D. Inductive interactions during kidney development. Semin Nephrol 1995, 15:255-262.
136. Badid C., Mounier N., Costa A.M., Desmouliere A. Role of myofibroblasts during normal tissue repair and excessive scarring: interest of their assessment in nephropathies. Histol Histopathol 2000, 15:269-280.
137. Schmitt-Graff A., Desmouliere A., Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch 1994, 425:3-24.
138. Diamond J.R., van Goor H., Ding G., Engelmyer E. Myofibroblasts in experimental hydronephrosis. Am J Pathol 1995, 146:121-129.
139. Gobet R., Bleakley J., Cisek L., et al. Fetal partial urethral obstruction causes renal fibrosis and is associated with proteolytic imbalance. J Urol 1999, 162:854-860.
140. Chevalier R.L., Goyal S., Wolstenholme J.T., Thornhill B.A. Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor. Kidney Int 1998, 54:38-47.
141. Eddy A.A. Molecular insights into renal interstitial fibrosis [editorial]. J Am Soc Nephrol 1996, 7:2495-2508.
142. Weber K.T. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin Nephrol 1997, 17:467-491.
143. Misseri R., Meldrum K.K. Mediators of fibrosis and apoptosis in obstructive uropathies. Curr Urol Rep 2005, 6:140-145.
144. Restrepo N., Kees-Folts D., Ding G., et al. Tubulointerstitial macrophages, transforming growth factor-beta, and monocyte chemoattractant peptide (MCP)-1 after unilateral ureteral obstruction. J Am Soc Nephrol 1993, 4:781.
145. Diamond J.R., Ricardo S.D., Klahr S. Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin Nephrol 1998, 18:594-602.
146. Engelmyer E., van Goor H., Edwards D.R., Diamond J.R. Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase -1, -2, and -3 in experimental hydronephrosis. J Am Soc Nephrol 1995, 5:1675-1683.
147. Mure P.Y., Gelas T., Dijoud F., et al. Complete unilateral ureteral obstruction in the fetal lamb, part II: long-term outcomes of renal tissue development. J Urol 2006, 175:1548-1558.
148. Sharma K., Eltayeb B.O., McGowan T.A., et al. Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis 1999, 34:818-823.
149. Massague J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett 2006, 580:2811-2820.
150. Yoo K.H., Thornhill B.A., Wolstenholme J.T., Chevalier R.L. Tissue-specific regulation of growth factors and clustering by angiotensin II. Am J Hypertens 1998, 11:715-722.
151. Yoo K.H., Wolstenholme J.T., Chevalier R.L. Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney. Pediatr Res 1997, 42:588-592.
152. Kellner D., Chen J., Richardson I., et al. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. J Urol 2006, 176:806-812.
153. Ishidoya S., Morrissey J., McCracken R., et al. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995, 47:1285-1294.
154. Kaneto H., Morrissey J., McCracken R., et al. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994, 45:1637-1647.
155. Everett A.D., Tufro-McReddie A., Fisher A., Gomez R.A. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension 1994, 23:587-592.
156. Eddy A.A. Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome. Am J Physiol 1994, 266:F884-893.
157. Yang J., Dai C., Liu Y. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am J Pathol 2003, 163:621-632.
158. Yang J., Liu Y. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2003, 284:F349-F357.
159. Robillard J.E., Page W.V., Mathews M.S., et al. Differential gene expression and regulation of renal angiotensin II receptor subtypes (AT1 and AT2) during fetal life in sheep. Pediatr Res 1995, 38:896-904.
160. Gimonet V., Bussieres L., Medjebeur A.A., et al. Nephrogenesis and angiotensin II receptor subtypes gene expression in the fetal lamb. Am J Physiol 1998, 274:F1062-F1069.
161. Gobet R., Park J.M., Nguyen H.T., et al. Renal renin-angiotensin system dysregulation caused by partial bladder outlet obstruction in fetal sheep. Kidney Int 1999, 56:1654-1661.
162. Yoo K.H., Norwood V.F., el-Dahr S.S., et al. Regulation of angiotensin II AT1 and AT2 receptors in neonatal ureteral obstruction. Am J Phys 1997, 273:R503-R509.
163. Gomez R.A., Lynch K.R., Chevalier R.L., et al. Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol 1988, 254:F900-F906.
164. Fern R.J., Yesko C.M., Thornhill B.A., et al. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 1999, 103:39-46.
165. Gomez R.A., Tufro-McReddie A., Norwood V.F., et al. Renin-angiotensin system: kidney growth and development. Exp Nephrol 1994, 2:130.
166. Diamond J.R., Kees-Folts D., Ding G., et al. Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 1994, 266:F926-F933.
167. Diamond J.R. Macrophages and progressive renal disease in experimental hydronephrosis. Am J Kidney Dis 1995, 26:133-140.
168. Diamond J.R., Kees-Folts D., Ricardo S.D., et al. Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 1995, 146:1455-1466.
169. Ricardo S.D., Ding G., Eufemio M., Diamond J.R. Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors. Am J Physiol 1997, 272:F789-F798.
170. Sheehan S.J., Moran K.T., Dowsett D.J., Fitzpatrick J.M. Renal haemodynamics and prostaglandin synthesis in partial unilateral ureteric obstruction. Urol Res 1994, 22:279-285.
171. Sankari B.R., Steinhardt G.F., Salinas-Madrigal L., Spry L.A. Urinary PGE2 in rats with chronic partial unilateral ureteral obstruction. J Surg Res 1991, 51:253-258.
172. Felsen D., Loo M.H., Marion D.N., Vaughan E.D. Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction. J Urol 1990, 144:141-145.
173. Moody T.E., Vaughn E.D., Gillenwater J.Y. Relationship between renal blood flow and ureteral pressure during 18 hours of total unilateral urethral occlusion: implications for changing sites of increased renal resistance. Invest Urol 1975, 13:246-251.
174. Moody T.E., Vaughan E.D., Gillenwater J.Y. Comparison of the renal hemodynamic response to unilateral and bilateral ureteral occlusion. Invest Urol 1977, 14:455-459.
175. Moody T.E., Vaughan E.D., Wyker A.T., Gillenwater J.Y. The role of intrarenal angiotensin II in the hemodynamic response to unilateral obstructive uropathy. Invest Urol 1977, 14:390-397.
176. Mure P.Y., Gelas T., Benchaib M., et al. Complete unilateral ureteral obstruction in the fetal lamb, part I: long-term outcomes of renal hemodynamics and anatomy. J Urol 2006, 175:1541-1547.
177. Bogaert G.A., Mevorach R.A., Kogan B.A. Renal hemodynamic and functional effects of 10 days' partial urinary obstruction in the fetal lamb. J Urol 1994, 152:220-225.
178. Bogaert G.A., Gluckman G.R., Mevorach R.A., Kogan B.A. Renal preservation despite 35 days of partial bladder obstruction in the fetal lamb. J Urol 1995, 154:694-699.
179. Bogaert G.A., Kogan B.A., Mevorach R.A. Effects of endothelium-derived nitric oxide on renal hemodynamics and function in the sheep fetus. Pediatr Res 1993, 34:755-761.
180. Ito K., Chen J., Seshan S.V., et al. Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int 2005, 68:515-528.
181. Ito K., Chen J., El Chaar M., et al. Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol Renal Physiol 2004, 287:F1283-F1293.
182. Ito K., Chen J., Vaughan E.D., et al. Dietary L-arginine supplementation improves the glomerular filtration rate and renal blood flow after 24 hours of unilateral ureteral obstruction in rats. J Urol 2004, 171:926-930.
183. Felsen D., Schulsinger D., Gross S.S., et al. Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction: the role of nitric oxide. J Urol 2003, 169:373-376.
184. el Dahr S.S., Gomez R.A., Gray M.S., et al. Renal nerves modulate renin gene expression in the developing rat kidney with ureteral obstruction. J Clin Invest 1991, 87:800-810.
185. Peters C.A., Gaertner R.C., Carr M.C., Mandell J. Fetal compensatory renal growth due to unilateral ureteral obstruction. J Urol 1993, 150:597-600.
186. Glick P.L., Harrison M.R., Adzick N.S., et al. Correction of congenital hydronephrosis in utero, IV: in utero decompression prevents renal dysplasia. J Pediatr Surg 1984, 19:649-656.
187. Adzick N.S., Harrison M.R., Flake A.W., Laberge J.M. Development of a fetal renal function test using endogenous creatinine clearance. J Pediatr Surg 1985, 20:602-607.
188. Ward R.M., Starr N.T., Snow B.W., et al. Serial renal function in an ovine model of unilateral fetal urinary tract obstruction. J Urol 1989, 142:652-656.
189. Bussieres L., Wieckowski J., Revillon Y., et al. Creation of experimental urethral obstruction in utero: evaluation of fetal renal function. Eur J Pediatr Surg. 1993, 3:161-165.
190. Steinhardt G., Salinas-Madrigal L., Farber R., et al. Experimental ureteral obstruction in the fetal opossum, I: renal functional assessment. J Urol. 1990, 144:564-566.
191. Boineau F., Vari R., Lewy J. Reversible vasoconstriction in rats with congenital unilateral hydronephrosis. Pediatr Nephrol 1987, 1:498-501.
192. Fichtner J., Boineau F.G., Lewy J.E., et al. Congenital unilateral hydronephrosis in a rat model: continuous renal pelvic and bladder pressures. J Urol. 1994, 152:652-657.
193. Seseke F., Thelen P., Heuser M., et al. Impaired nephrogenesis in rats with congenital obstructive uropathy. J Urol 2001, 165:2289-2292.
194. Pope J.C.T., Brock J.W., Adams M.C., et al. How they begin and how they end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract. CAKUT. J Am Soc Nephrol 1999, 10:2018-2028.
195. Miyazaki Y., Tsuchida S., Fogo A., Ichikawa I. The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. Kidney Int 1999, 55:1683-1695.
196. Josephson S., Wolgast M., Ojteg G. Experimental obstructive hydronephrosis in newborn rats, II: long-term effects on renal blood flow distribution. Scand J Urol Nephrol 1982, 16:179-185.
197. Claesson G., Josephson S., Robertson B. Experimental partial ureteric obstruction in newborn rats, IV: do the morphological effects progress continuously?. J Urol 1983, 130:1217-1222.
198. Josephson S. Experimental obstructive hydronephrosis in newborn rats, III: long-term effects on renal function. J Urol 1983, 129:396-400.
199. Josephson S. Experimental obstructive hydronephrosis in newborn rats, V: long-term effects on renal tissue solute content. J Urol 1985, 133:1099-1103.
200. Josephson S., Ericson A.C., Sjoquist M. Experimental obstructive
201. Claesson G., Josephson S., Robertson B. Experimental partial ureteric obstruction in newborn rats, VII: are the long term effects on renal morphology avoided by release of the obstruction?. J Urol 1986, 136:1330-1334.
202. Ulm A.H., Miller F. An operation to produce experimental reversible hydronephrosis in dogs. J Urol. 1962, 88:337.
203. Chevalier R.L. Chronic partial ureteral obstruction in the neonatal guinea pig, II: pressure gradients affecting glomerular filtration rate. Pediatr Res 1984, 18:1271-1277.
204. Chevalier R.L., Kaiser D.L. Chronic partial ureteral obstruction in the neonatal guinea pig, I: influence of uninephrectomy on growth and hemodynamics. Pediatr Res 1984, 18:1266-1271.
205. el Dahr S.S., Gomez R.A., Gray M.S., et al. In situ localization of renin and its mRNA in neonatal ureteral obstruction. Am J Physiol 1990, 258(Pt 2):F854.
206. Silverstein D.M., Travis B.R., Thornhill B.A., et al. Altered expression of immune modulator and structural genes in neonatal unilateral ureteral obstruction. Kidney Int 2003, 64:25-35.
207. Thornhill B.A., Burt L.E., Chen C., et al. Variable chronic partial ureteral obstruction in the neonatal rat: a new model of ureteropelvic junction obstruction. Kidney Int 2005, 67:42-52.
208. Josephson S., Grossmann G. Partial ureteric obstruction in the pubescent rat, II: long-term effects on the renal morphology. Urol Int 1991, 47:126-130.
209. Stenberg A., Jacobsson E., Larsson E., Persson A.E. Long-term partial ureteral obstruction and its effects on kidney function. Scand J Urol Nephrol 1992, 26:35-41.
210. Taki M., Goldsmith D.I., Spitzer A. Impact of age on effects of ureteral obstruction on renal function. Kidney Int 1983, 24:602-609.
211. Chevalier R.L., Sturgill B.C., Jones C.E., Kaiser D.L. Morphologic correlates of renal growth arrest in neonatal partial ureteral obstruction. Pediatr Res 1987, 21:338-346.
212. Chung K.H., Chevalier R.L. Arrested development of the neonatal kidney following chronic ureteral obstruction. J Urol 1996, 155:1139-1144.
213. Eskild-Jensen A., Christensen H., Lindvig M., et al. Renal functional outcome in unilateral hydronephrosis in newborn pigs. J Urol 2000, 163:1896-1900.
214. Eskild-Jensen A., Jacobsen L., Christensen H., et al. Renal function outcome in unilateral hydronephrosis in newborn pigs, II: function and volume of contralateral kidneys. J Urol 2001, 165:205-209.
215. Chevalier R.L., Kim A., Thornhill B.A., Wolstenholme J.T. Recovery following relief of unilateral ureteral obstruction in the neonatal rat. Kidney Int 1999, 55:793-807.
216. Eskild-Jensen A., Munch Jorgensen T., Olsen L.H., et al. Renal function may not be restored when using decreasing differential function as the criterion for surgery in unilateral hydronephrosis. BJU Int 2003, 92:779-782.
217. Chevalier R.L. Biomarkers of congenital obstructive nephropathy: Past, present and future. J Urol 2004, 172:852-857.
218. Carr M.C., Peters C.A., Retik A.B., Mandell J. Urinary levels of the renal tubular enzyme N-acetyl-beta-d-glucosaminidase in unilateral obstructive uropathy. J Urol 1994, 151:442-445.
219. Decramer S., Wittke S., Mischak H., et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 2006, 12:398-400.
220. Chevalier R.L. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol 2006, 2:157-168.
221. Furness P.D., Maizels M., Han S.W., et al. Elevated bladder urine concentration of transforming growth factor-beta1 correlates with upper urinary tract obstruction in children. J Urol 1999, 162:1033-1036.
222. Han D.C., Hoffman B.B., Hong S.W., et al. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol 2000, 278:F628-F634.
223. Inazaki K., Kanamaru Y., Kojima Y., et al. Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int 2004, 66:597-604.
224. Eskild-Jensen A., Thomsen K., Rungo C., et al. Glomerular and tubular function during AT1 receptor blockade in pigs with neonatal induced partial ureteropelvic obstruction. Am J Physiol Renal Physiol 2007, 292:F921-F929.
225. Topcu S.O., Pedersen M., Norregaard R., et al. Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. Am J Physiol Renal Physiol 2007, 292:F736-F748.
226. Reaves P.Y., Gelband C.H., Wang H., et al. Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring. Circ Res 1999, 85:e44-e50.